Skip to Main Content

Author Details

Anthony D Pomicter
Huntsman Cancer Institute, University of Utah
2009
39
19
PMIDPaper TitleJournal TitlePublished Year
37645727Bioluminescence Assay of Lysine Deacylase Sirtuin Activity.bioRxiv2023
38081125JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome.J Natl Compr Canc Netw2023
34780648MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.Blood2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
35876645Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.Br J Haematol2022
33412552Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.Acta Haematol2021
34916286Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.Proc Natl Acad Sci U S A2021
34027418SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.Blood Cancer Discov2021
32409689Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.Leukemia2020
31980730Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.Leukemia2020
30563936Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.Clin Cancer Res2019
31697804JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera.Blood2019
31648319The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.Blood Adv2019
30026572Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.Leukemia2019
31493432BCR-ABL1 tyrosine kinase inhibitor K0706 exhibits preclinical activity in Philadelphia chromosome-positive leukemia.Exp Hematol2019
31543464Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.Cancer Cell2019
31540978ddeeper Than Deep: Can ddPCR Predict Successful Imatinib Cessation?Clin Cancer Res2019
28579617HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.Leukemia2018
29588547Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective.Leukemia2018
29749399Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion.Leukemia2018
29707154Similar expression profiles in CD34<sup>+</sup> cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib.Oncotarget2018
29284681A novel <i>AGGF1-PDGFRb</i> fusion in pediatric T-cell acute lymphoblastic leukemia.Haematologica2018
28819281Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib.Leukemia2017
28465516Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.Leukemia2017
27480386Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.Leukemia2016
26648538Age-related mutations and chronic myelomonocytic leukemia.Leukemia2016
26582647Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia.Leukemia2016
25134459Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.Leukemia2015
26202934β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.Leukemia2015
25912019Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.Exp Hematol2015
25573989shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.Blood2015
25132497BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.Cancer Cell2014
23223358BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.Blood2013
24081651Nfasc155H and MAG are specifically susceptible to detergent extraction in the absence of the myelin sphingolipid sulfatide.Neurochem Res2013
23887971KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors.Cancer Res2013
20888080Paranodal reorganization results in the depletion of transverse bands in the aged central nervous system.Neurobiol Aging2012
19379822Myelin, DIGs, and membrane rafts in the central nervous system.Prostaglandins Other Lipid Mediat2010
20129933Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis.Brain2010
19224580Adult CST-null mice maintain an increased number of oligodendrocytes.J Neurosci Res2009
  • 1 - 39 of 39

Recommended Authors

Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Brett M Stevens
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 7
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 32
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 3
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 1
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 7
Sabine Taschner-Mandl
St. Anna Children's Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 0
Arun P Wiita
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 0
Stephen T Oh
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 34
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
Peter Kurre
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 10
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 3
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 22
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 12
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 3
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 4
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 4
Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 0
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 4
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Career Start Year 1991
Number of shared co-authors 1
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 5
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 6
Marcela Gronda
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 3
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 3
Toshio Kitamura
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
Daniel C Link
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 1
Paul Brent Ferrell
Vanderbilt University
Career Start Year 1981
Number of shared co-authors 2

Collaborators

Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 32
Thomas O'Hare
Huntsman Cancer Institute, University of Utah
Co-authored papers 25
Dongqing Yan
Inner Mongolia University
Co-authored papers 15
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Co-authored papers 15
Jamshid S Khorashad
Institute of Cancer Research
Co-authored papers 14
Matthew S Zabriskie
University of Utah
Co-authored papers 13
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Co-authored papers 10
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Co-authored papers 10
Brian J Druker
Oregon Health & Science University
Co-authored papers 9
Anna Senina
Huntsman Cancer Institute, The University of Utah
Co-authored papers 9
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Hein Than
Singapore General Hospital
Co-authored papers 6
Hannah M Redwine
Huntsman Cancer Institute, The University of Utah
Co-authored papers 5
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 5
Jonathan M Ahmann
Huntsman Cancer Institute, The University of Utah
Co-authored papers 5
Anca Franzini
University of Utah
Co-authored papers 5
Amber D Bowler
Huntsman Cancer Institute, The University of Utah
Co-authored papers 4
Riccardo Baron
Co-authored papers 3
Thoralf Lange
Hospital Weissenfels
Co-authored papers 3
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Katherine E Varley
Huntsman Cancer Institute
Co-authored papers 2
Anna Reister Schultz
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Kara Johnson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Richard Moriggl
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 2
Samantha L Savage
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Diana Resetca
University of Toronto
Co-authored papers 2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Jorge Cortes
Georgia Cancer Center
Co-authored papers 2
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 2
Release 1.2